跳至主要内容
临床试验/NCT01761422
NCT01761422进行中(未招募)不适用

Myocardial Inflammation in Systemic Lupus Erythematosus

Stacy Ardoin MD1 个研究点 分布在 1 个国家目标入组 40 人开始时间: 2012年7月1日最近更新:
适应症

试验速览

阶段
不适用
状态
进行中(未招募)
发起方
入组人数
40
试验地点
1
主要终点
T2 edema on Cardiac MRI

研究概览

简要总结

The goal is to assess for myocardial edema on cardiac MRI during SLE flare to assess for myocardial inflammation.

详细描述

The over-arching goal of this work is to further the understanding of myocardial damage in systemic lupus erythematosus (SLE) using state of the art CV imaging to investigate a novel potential mechanism of CV injury in SLE, subclinical myocardial inflammation.

Aim 1: Investigate an alternative pathway for CV morbidity in SLE by measuring myocardial edema at time of moderate to severe flare and compare values to post-flare studies and historical healthy controls.

Hypothesis 1: Myocardial edema, measured quantitatively with T2 CMR mapping during moderate to severe SLE flare will be significantly increased compared to 1) historical controls and 2) in SLE patients after resolution of flare.

Aim 2: Perform exploratory analyses investigating relationships between myocardial edema on CMR and markers of SLE disease activity and CV risk factors.

Hypothesis 2: Markers of disease activity including inflammatory makers (ESR and high sensitivity c-reactive protein), complement and autoantibody levels will predict the presence of T2 CMR detected myocardial edema during flare.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
18 Years 至 60 Years(Adult)
性别
All
接受健康志愿者

入选标准

  • • Diagnosis of SLE by American College of Rheumatology Classification Criteria [21]
  • Active SLE Flare defined by Systemic Lupus Erythematosus Disease Activity Index (SLEDAI)[22] > 6 or British Isles Lupus Assessment Group (BILAG) Index A or B.[23]

排除标准

  • Allergy to gadolinium
  • Severe claustrophobia
  • Renal replacement therapy or glomerular filtration rate (GFR) < 30 mL/min/1.75m²
  • Medically unstable for transportation to Ross MRI scanner. Stability will be defined as: not on mechanical ventilation, HR < 120 BPM, MAP > 65 mmHg. The treating providers' input on the patient's stability will also be considered in addition to these criteria
  • Weight > 500 pounds
  • MR incompatible implanted devices such as neurostimulator pacemakers and implantable defibrillators, presence of intracranial metal or any metal not compatible with CMR

结局指标

主要结局

T2 edema on Cardiac MRI

时间窗: 3 months

Compare T2 edema at flare and 3 months later

次要结局

未报告次要终点

研究者

发起方
Stacy Ardoin MD
申办方类型
Other
责任方
Sponsor Investigator
主要研究者

Stacy Ardoin MD

Assistant Professor-Clinical

Ohio State University

研究点 (1)

Loading locations...

相似试验